Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 8:10 pm Sale |
2023-12-31 | 13G | Palisade Bio, Inc. PALI |
Lind Global Fund II LP | 10,557 1.700% |
-38,997 (-78.70%) |
Filing History |
| 2024-02-13 8:09 pm Purchase |
2023-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ |
Lind Global Fund II LP | 125,520 3.900% |
125,520 (New Position) |
Filing History |
| 2024-02-13 8:09 pm Purchase |
2023-12-31 | 13G | Mobiquity Technologies, Inc. MOBQ |
Lind Global Fund II LP | 405,000 9.900% |
405,000 (New Position) |
Filing History |
| 2024-02-13 8:08 pm Purchase |
2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 93,889 9.900% |
55,499 (+144.57%) |
Filing History |
| 2024-02-13 8:08 pm Purchase |
2023-12-31 | 13G | Intelligent Bio Solutions Inc. INBS |
Lind Global Fund II LP | 960,000 9.900% |
927,833 (+2884.46%) |
Filing History |
| 2024-02-13 8:06 pm Purchase |
2023-12-31 | 13G | GSE Systems, Inc. GVP |
Lind Global Fund II LP | 300,568 9.900% |
300,568 (New Position) |
Filing History |
| 2024-02-13 8:06 pm Sale |
2023-12-31 | 13G | Grom Social Enterprises, Inc. GROM |
Lind Global Fund II LP | 0 0.000% |
-12,004 (Position Closed) |
Filing History |
| 2024-02-13 8:05 pm Purchase |
2023-12-31 | 13G | Energy Focus, Inc. EFOI |
Lind Global Fund II LP | 117,508 2.600% |
117,508 (New Position) |
Filing History |
| 2024-02-13 8:05 pm Purchase |
2023-12-31 | 13G | Edible Garden AG Incorporated EDBL |
Lind Global Fund II LP | 1,144 9.900% |
744 (+185.91%) |
Filing History |
| 2024-02-13 8:05 pm Sale |
2023-12-31 | 13G | CEA Industries Inc. CEAD |
Lind Global Fund II LP | 34,583 4.900% |
-11,658 (-25.21%) |
Filing History |
| 2024-02-13 8:04 pm Purchase |
2023-12-31 | 13G | Blue Star Foods Corp. BSFC |
Lind Global Fund II LP | 31,800 9.900% |
31,800 (New Position) |
Filing History |
| 2024-02-13 8:04 pm Purchase |
2023-12-31 | 13G | BIO-key International, Inc. BKYI |
Lind Global Fund II LP | 46,285 4.700% |
46,285 (New Position) |
Filing History |
| 2024-02-13 8:03 pm Purchase |
2023-12-31 | 13G | BIOLASE INC PAR $.001 BIOLQ |
Lind Global Fund II LP | 9,210 0.400% |
9,210 (New Position) |
Filing History |
| 2024-02-13 8:03 pm Purchase |
2023-12-31 | 13G | Bone Biologics Corporation BBLG |
Lind Global Fund II LP | 34,180 6.000% |
34,180 (New Position) |
Filing History |
| 2024-02-13 8:03 pm Purchase |
2023-12-31 | 13G | Golden Minerals Company AUMN |
Lind Global Fund II LP | 1,502,477 9.900% |
142,477 (+10.48%) |
Filing History |
| 2024-02-13 8:02 pm Sale |
2023-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Lind Global Fund II LP | 0 0.000% |
-3,000,000 (Position Closed) |
Filing History |
| 2024-02-13 8:02 pm Purchase |
2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Lind Global Fund II LP | 44,750 1.800% |
44,750 (New Position) |
Filing History |
| 2024-02-13 8:00 pm Sale |
2023-12-31 | 13G | Talphera, Inc. TLPH |
Lind Global Fund II LP | 735,296 4.200% |
-367,648 (-33.33%) |
Filing |
| 2024-02-13 7:59 pm Purchase |
2023-12-31 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 770,000 9.900% |
770,000 (New Position) |
Filing History |
| 2024-02-09 09:00 am Purchase |
2024-02-06 | 13G | Cingulate Inc. CING |
Lind Global Fund II LP | 23,500 9.900% |
23,500 (New Position) |
Filing History |